Ligand Pharmaceuticals (NASDAQ:LGND) said that the FDA has approved its topical gel product Zelsuvmi for the treatment of molluscum contagiosum, a highly contagious viral skin infection.

The molluscum contagiosum (MC) virus (MCV) is a dermatotropic poxvirus, and the causative agent of MC. Unlike smallpox and human monkeypox diseases, MC is nonlethal, common and worldwide.

(RTTNews) - Verrica Pharmaceuticals Inc. (VRCA) a dermatology therapeutics company, announced on Friday that its partner, Torii Pharmaceutical Co. Ltd., has submitted a New Drug Application ...